A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

about

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

Item

http://www.wikidata.org/entity/Q52720139

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

@en

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

@nl

type

Item

label

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

@en

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

@nl

prefLabel

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

@en

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

@nl

P1476

A superelderly case of TAFRO syndrome treated effectively using corticosteroid hormones.

@en

P2093

Hitoshi Yamazaki

http://www.w3.org/2001/XMLSchema#string

Mizuho Adachi

http://www.w3.org/2001/XMLSchema#string

Noritada Kobayashi

http://www.w3.org/2001/XMLSchema#string

Takemichi Okada

http://www.w3.org/2001/XMLSchema#string

Yasushi Nagaba

http://www.w3.org/2001/XMLSchema#string

Yoshitaka Shimada

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombocytopenia with reticulin fibrosis accompanied by fever, anasarca and hepatosplenomegaly : a clinical report of five cases.

Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?

Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease.

Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

The impact of ageing on natural killer cell function and potential consequences for health in older adults

Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a s

CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.

P304

638-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1002/CCR3.1417

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hiroaki Yokomori

P577

2018-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29636931

http://www.w3.org/2001/XMLSchema#string

P932

5889227

http://www.w3.org/2001/XMLSchema#string